Zampino Daniela, Mancuso Monique, Zaccone Renata, Ferreri Tiziana, Borzacchiello Assunta, Zeppetelli Stefania, Dattilo Sandro, Ussia Martina, Ferreri Loredana, Carbone Domenico C, Recca Giuseppe, Puglisi Concetto
Institute of Polymers, Composites and Biomaterials (IPCB)-CNR, Section of Catania, Via Paolo Gaifami 18, 95126 Catania, Italy.
Institute for Biological Resources and Marine Biotechnology (IRBIM)-CNR, Section of Messina, Spianata San Raineri 86, 98122 Messina, Italy.
Mater Sci Eng C Mater Biol Appl. 2021 Mar;122:111920. doi: 10.1016/j.msec.2021.111920. Epub 2021 Jan 29.
The aim of this study was the development of antimicrobial polyvinylchloride (PVC) blends loaded with 0.1-10% (w/w) of the ILs 1-hexadecyl-3-methylimidazolium 1,3-dimethyl 5-sulfoisophthalate (HdmimDMSIP) and 1-octyloximethyl-3-methylimidazolium hexafluorophosphate (OOMmimPF). The synthetized ILs were characterized by HNMR, MALDI-TOF, DSC and TGA. PVC/ILs films were obtained by solvent casting.Thermal and mechanical properties (tensile stress TS and elongation at break EB), morphology by SEM, surface wettability, antimicrobial activity, cytotoxicity and ILs release in sterile water from PVC/ILs film blends were determined. Results demonstrated that the presence of both ILs in PVC formulation slightly affected thermal and mechanical properties of blends. The loading of both ILs into PVC matrix made PVC/ILs films hydrophilic, especially at the highest concentration of HdmimDMSIP. The PVC/ILs blends displayed antibacterial activity up to ILs lowest concentrations (0.1-0.5%). The inhibition of Escherichia coli growth was lower than that showed toward Staphylococcus epidermidis. The addition of 10% ILs concentration resulted excessive as demonstrated by accumulation of ILs on film surfaces (SEM) and ILs high release from PVC/ILs blends during the first day of water immersion. Biocompatibility studies highlighted that the addition of low amounts of both ILs into PVC matrix is not cytotoxic for mouse fibroblast cells (L929), supporting their potential use for biomedical porposes.
本研究的目的是开发负载有0.1 - 10%(w/w)的离子液体1 - 十六烷基 - 3 - 甲基咪唑鎓1,3 - 二甲基5 - 磺基间苯二甲酸酯(HdmimDMSIP)和1 - 辛氧基甲基 - 3 - 甲基咪唑鎓六氟磷酸盐(OOMmimPF)的抗菌聚氯乙烯(PVC)共混物。通过核磁共振氢谱(HNMR)、基质辅助激光解吸电离飞行时间质谱(MALDI - TOF)、差示扫描量热法(DSC)和热重分析法(TGA)对合成的离子液体进行了表征。通过溶液浇铸法制备了PVC/离子液体薄膜。测定了其热性能和力学性能(拉伸应力TS和断裂伸长率EB)、扫描电子显微镜(SEM)观察的形态、表面润湿性、抗菌活性、细胞毒性以及PVC/离子液体薄膜共混物在无菌水中的离子液体释放情况。结果表明,PVC配方中两种离子液体的存在对共混物的热性能和力学性能有轻微影响。将两种离子液体负载到PVC基体中使PVC/离子液体薄膜具有亲水性,尤其是在HdmimDMSIP浓度最高时。PVC/离子液体共混物在离子液体最低浓度(0.1 - 0.5%)时表现出抗菌活性。对大肠杆菌生长的抑制作用低于对表皮葡萄球菌的抑制作用。10%离子液体浓度的添加量过多,这从薄膜表面离子液体的积累(SEM)以及PVC/离子液体共混物在水浸泡第一天的高离子液体释放量可以看出。生物相容性研究强调,向PVC基体中添加少量的两种离子液体对小鼠成纤维细胞(L929)无细胞毒性,支持了它们在生物医学用途方面的潜在应用。